Biology
Confirm the subtype
ER, PR, HER2 and the complete pathology report shape the treatment pathway.
Breast Cancer · Recurrence
Recurrent Breast Cancer Treatment: Reassess the Biology and the Options
A recurrence deserves a new evaluation. Location, timing, symptoms, prior therapy and current biomarkers determine whether the next plan is local, systemic or both.
Answer first: A recurrence deserves a new evaluation. Location, timing, symptoms, prior therapy and current biomarkers determine whether the next plan is local, systemic or both.
Cancer Consultation
Speak With Our Cancer Patient Care Team
Tell us where you are in your cancer journey. Our Patient Care Team can answer questions and help determine the next step.
*
Required fields
Prefer to speak with someone now?
1-800-923-7878
✓
Stage 4 & advanced cancer patients welcome
✓
Out-of-state & international patients welcome
✓
Questions before scheduling are welcome
Understand the treatment question
The next step begins with accurate, current information.
Extent
Define where disease is present
Imaging, examination and symptoms clarify local, regional or distant disease.
History
Learn from prior response
What worked, what stopped working and what was tolerated all influence sequencing.
Treatment pathways
Use stage, biomarkers and goals to organize options.
Local treatment
Surgery and radiation may be relevant for primary, local or regional disease and for selected symptomatic metastatic sites.
Systemic treatment
Endocrine therapy, HER2-directed therapy, chemotherapy, immunotherapy, antibody-drug conjugates and mutation-directed treatment are considered according to subtype and setting.
Clinical trials and second opinions
A trial or pathology review may be especially useful when disease is uncommon, changing or resistant to prior treatment.
Natural and integrative care
A whole-person program built around the actual case.
Infusion therapies
IV vitamin C and glutathione
Physician-directed infusion support is considered with labs, medications, organ function and goals.
Botanicals
Mistletoe and polyphenols
Mistletoe, curcumin, resveratrol, silymarin and EGCG are discussed according to evidence level and formulation.
Immune context
Immune and NK-cell testing
Selected measurements may add context but are not a substitute for validated tumor biomarkers.
Emerging modality
Hydrogen inhalation
Molecular hydrogen is included as an emerging supportive modality with early human oncology research.
A Sunridge consultation
Turn information into a personalized next step.
- Physician review of records and prior treatment.
- Identification of missing pathology, biomarker or hereditary information.
- A natural and integrative program aligned with present health and goals.
- Travel planning for patients coming to Scottsdale.
Questions patients ask
Common questions
Can this page replace an individualized consultation?
No. It explains the decision framework; a real plan requires the complete records and clinical context.
Does Sunridge welcome complex or advanced cases?
Yes. Newly diagnosed, recurrent, metastatic and previously treated patients may request a physician review.
A closer look
How this topic fits the complete breast-cancer plan.
Recurrence may be local in the breast or chest wall, regional in nearby lymph nodes, or distant in organs or bone. That distinction changes the intent and structure of treatment. A late, isolated local recurrence raises different possibilities from an early multi-site recurrence. When feasible, biopsy can confirm that the finding is breast cancer and determine whether ER, PR or HER2 status has changed.
The review should reconstruct the full timeline: original pathology, surgery, radiation fields, systemic medicines, duration of response, surveillance findings, new symptoms and current imaging. It should also ask whether hereditary or tumor genomic testing is incomplete. Sunridge uses this updated map to discuss a coordinated integrative program rather than assuming that the plan used at the original diagnosis still fits the recurrent disease.
Prepare for a Sunridge review
The right records make the first conversation more useful.
Before contacting the Patient Care Team, gather the original and recurrent pathology, prior surgery and radiation details, systemic-treatment timeline, new imaging and present symptoms. A concise one-page chronology is often helpful: diagnosis date, stage, major test results, treatments received, response, side effects and the questions that matter most now.
Step 1
Send the records
The team can explain which reports and images are needed before a physician review.
Step 2
Define the priorities
List the treatment, symptom, recovery and quality-of-life questions you want the consultation to address.
Step 3
Plan the visit
Out-of-state and international patients can discuss timing, Scottsdale travel and which services require an in-person appointment.
Continue exploring
Explore Sunridge integrative therapies
Learn how these physician-directed therapies are evaluated within a personalized cancer-care program.
A personalized next step
Bring the complete breast-cancer story to the conversation.
Our Patient Care Team can explain which records to send, how a physician review works and what to expect when traveling to Scottsdale.
Request a consultationCall 1-800-923-7878This page is educational and does not provide a diagnosis or individualized treatment recommendation. Medication and integrative-treatment decisions require review of the complete case by qualified clinicians. Content reviewed August 2026.